Prostatic Neoplasms: all 6,484 studies
Page 10 of 65. Open to participants first (1,415), then studies with results posted, then the rest; newest registration first within each.
- Abiraterone and Prednisone or Darolutamide for the Treatment of Advanced Prostate CancerRecruitingNCT06173362Phase 2
- A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid TumorsRecruitingNCT06172478Phase 2
- Intermittent Fasting in Prostate Cancer Patients Receiving Androgen Deprivation TherapyRecruitingNCT06172283Not applicable
- Using MRI to Identify Areas to Receive Lower Doses of Radiation Treatment in Men With Prostate Cancerdose Mapping to Preserve Quality of LifeRecruitingNCT06171269Not applicable
- Tumor Genomic Pre-test Counseling Tool for Black or African-American Men With Prostate CancerRecruitingNCT06171139Not applicable
- Telmisartan in Prostate CancerRecruitingNCT06168487Phase 1
- Monocentric Observational Study on the Diagnostic and Prognostic Role of 18F-PSMA PET (PET/CT and PET/MR) in Prostate CancerRecruitingNCT06167629
- Exercise in Prostate CancerRecruitingNCT06165302Not applicable
- The Effect of Multidisciplinary Care Approach on CV Risk Modification in CaP Patients Receiving ADTRecruitingNCT06163924
- Surface Electrical Stimulation for Urinary Incontinence in Men Treated for Prostate CancerRecruitingNCT06161506Phase 2
- MDRT in Prostate Cancer Treated With Long-term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA)RecruitingNCT06150417Phase 2
- Single Center Registration Study on HER2 Expression and Clinical Pathological Characteristics in Prostate CancerRecruitingNCT06146114
- Radiotherapy and Androgen Deprivation In Combination After Local Surgery (RADICALS) Translational StudyNot yet recruitingNCT06145958
- Vorinostat and 177Lu-PSMA-617 for the Treatment of PSMA-Low Metastatic Castration-Resistant Prostate CancerRecruitingNCT06145633Phase 2
- ARCTIC: Liquid Biomarkers in the Prospective Androgen Receptor Signaling Inhibitors (ARSI) Resistance Clinical TrialsRecruitingNCT06141993
- Phase 1/2 Clinical Study of Lutetium Lu 177 JH020002 Injection in Patients With Advanced Prostate CancerRecruitingNCT06139575Phase 1/2
- Patient Navigation Program to Improve Clinical Trial Enrollment in Cancer PatientsRecruitingNCT06138067Not applicable
- A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)RecruitingNCT06136650Phase 3
- Evaluation of the Concordance Between Pre-therapy Dosimetry Performed From 68Ga-PSMA-11 Dynamic PET and Post-treatment Dosimetry of 177Lu-PSMA-617 Vectorized Internal Radiotherapy in Patients With Metastatic Prostate Cancer Resistant to Hormonal Castration.Not yet recruitingNCT06136377Not applicable
- Rezvilutamide Plus Abiraterone for Metastatic Hormone-sensitive Prostate CancerNot yet recruitingNCT06134271Phase 2
- Relugolix in Combination With Radiation Therapy for Treating Patients With High Risk Prostate CancerNot yet recruitingNCT06129851Phase 2
- Diagnostic Performance of [18F]PSMA-1007 PET/CT Imaging in Patients With Newly-Diagnosed Prostate CancerRecruitingNCT06122584Phase 3
- Optimizing the Announcement of Advanced or Metastatic Prostate Cancer Using Animated Videos (CartDiag PROSTATE)Not yet recruitingNCT06117696
- The PRECISION Study: 3 Fractions of Prostate SBRT and RayPilot HypoCath Image GuidanceRecruitingNCT06117059Not applicable
- Creatine Supplementation and Resistance Training to Preserve Muscle Mass and Attenuate Cancer ProgressionRecruitingNCT06112990Phase 3
- The SUGAR Study; SBRT and Relugolix) for Prostate CancerRecruitingNCT06111781Phase 2
- The University of Miami Adapt (UAdapt) TrialRecruitingNCT06111313Phase 2
- Locally Ablative TherapY in Oligo-ProgressiVe GEnitourinary TumoRs (LAYOVER)RecruitingNCT06101290Not applicable
- Dalpiciclib Isethionate Tablets Combined With Abiraterone Acetate Tablets (I) and Prednisone Tablets (AA-P) Versus Placebo Combined With AA-P in Treatment of High-volume, Metastatic, Hormone-sensitive Prostate Cancer (mHSPC)Not yet recruitingNCT06099990Phase 1
- Pilot of 18F-DCFPyL-PSMA PET in mCRPC Patients Receiving 117Lu-Vipivotide TetraxetanRecruitingNCT06099093Phase 4
- Enzalutamide and PDS01ADC in PET Positive Recurrent Prostate Cancer (pprPC) Without Testosterone Lowering TherapyRecruitingNCT06096870Phase 2
- A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate CancerRecruitingNCT06095089Phase 1
- Image-guided Navigation During Robotic Sentinel Node RemovalRecruitingNCT06091072Not applicable
- Phase I/II Study of PEGylated Arginine Deiminase (ADI-PEG20) With Carboplatin and Cabazitaxel in Men With Aggressive Variant Prostate Cancers (AVPC)RecruitingNCT06085729Phase 1/2
- A Pilot Presurgical Trial of REGN5678 (Anti-PSMA x CD28) in Patients With High-risk, Localized Prostate Cancer Followed by Radical ProstatectomyRecruitingNCT06085664Phase 1/2
- Randomized Phase II Trial of Targeted Radiation With no Castration for McrpcRecruitingNCT06084338Phase 2
- Study of [177Lu] Lu-XT033 Injection in Patients With Metastatic Prostate CancerRecruitingNCT06081686Phase 1/2
- Cancer of the Prostate Treated With Focal Implantation of a RadioactivE SourceEnrolling by invitationNCT06080113Not applicable
- Continence, Sexual Function, Fitness and the Health of Men After Surgery for Prostate CancerRecruitingNCT06072911Not applicable
- All-in-One Prostate Cancer Staging with MRIRecruitingNCT06071195
- Determining Patterns In Trial Experiences of Recurrent Prostate Cancer PatientsNot yet recruitingNCT06070272
- A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate CancerRecruitingNCT06067841Phase 1
- Longitudinal Advanced Prostate Cancer Cohort (LAPCC)RecruitingNCT06067295
- Hormone Therapy (Apalutamide) and Image-guided Stereotactic Body Radiation Therapy for the Treatment of Patients With Prostate Cancer, HEATWAVE TrialRecruitingNCT06067269Phase 2
- NeoAdjuvant Theranostic Lutetium Study: The Nautilus TrialRecruitingNCT06066437Phase 1/2
- Pilot Study for Detection of PSMA-Low CRPC-NE Tumors With Fluciclovine PET/CTRecruitingNCT06062745Phase 1
- Phase I Clinical Study of HRS-9815 for PET/CT Imaging in Patients With Prostate CancerNot yet recruitingNCT06062355Phase 1
- Prostate Oligometastatic Cancer Management Driven by Disease Biology et/or Immunoactivity (PROMETEO)RecruitingNCT06060652
- Impact of Augmented Reality During Robot-assisted Radical ProstatectomyRecruitingNCT06059859Not applicable
- Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate CancerRecruitingNCT06059118Phase 2
- Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical ProstatectomyRecruitingNCT06056830Phase 3
- Clinical Study on 68Ga-PSMA-33 for PET/CT Imaging of Prostate CancerRecruitingNCT06054789Not applicable
- A Trial Evaluating Toxicity of SBRT and LDRB in Localized Prostate Cancer.RecruitingNCT06052683Not applicable
- Study of 177Lu-PSMA-0057 in Metastatic Prostate CancerRecruitingNCT06050239Early Phase 1
- EMBRACE: Exercising TogetherRecruitingNCT06049355Phase 2
- Clinical, Genetic and Environmental Determinants of Prostate Cancer Progression.RecruitingNCT06046131Not applicable
- Debunking the Frailty-sarcopenIa-ADT Axis in mEtastatic Prostate canceR With multiComponent Exercise: The FIERCE TrialRecruitingNCT06040125Not applicable
- Supraphysiological Androgen to Enhance Treatment Activity in Metastatic Castration-Resistant Prostate Cancer, SPECTRA StudyRecruitingNCT06039371Phase 2
- Microendoscopic EI Sensing for Real-time Intraoperative Surgical Margin AssessmentRecruitingNCT06039085
- A Study of Mental Health Care in People With CancerRecruitingNCT06037954Not applicable
- Increasing Access to Definitive Treatment for Prostate CancerNot yet recruitingNCT06034431Not applicable
- A Phase II Neoadjuvant Study of Darolutamide Plus ADT in Men With Localized Prostate CancerRecruitingNCT06029036Phase 2
- Two-fraction Versus Five-fraction Stereotactic Radiotherapy for Localized Prostate CancerRecruitingNCT06027892Not applicable
- Multiparametric Ultrasound for the Diagnosis of Clinically Significant Prostate CancerNot yet recruitingNCT06024772Phase 3
- An Open Label Phase II Study of First-Line Maintenance Enzalutamide Following Docetaxel Plus Androgen-Deprivation Therapy in Patients With Previously-Untreated, Metastatic, Castration-Naive Prostatic AdenocarcinomaNot yet recruitingNCT06015321Phase 2
- Internet-Based Lifestyle Intervention to Eradicate Obese Frailty in Prostate Cancer Survivors, iLIVERecruitingNCT06011499Not applicable
- A Journey Into Participation Patterns Among Metastatic Prostate Cancer PatientsNot yet recruitingNCT06009549
- Phase 1/2 Clinical Study of HRS-4357 in Patients With Advanced Prostate CancerNot yet recruitingNCT06006104Phase 1/2
- PSMA-Guided Ablation of the ProstateRecruitingNCT06003556Phase 2
- ARTEMIS-003: HS-20093 in Patients With Metastatic Castrate-resistant Prostate Cancer (mCRPC) and Advanced Solid TumorsRecruitingNCT06001255Phase 2
- Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate CancerRecruitingNCT05997615Phase 1
- Inter-observer Variability in the Segmentation of Prostate Tumour Lesions Using Multiparametric MRI (VARIOP)RecruitingNCT05996289
- The Remote Study: Investigating the Effects or Online Exercise on Quality of Life in Men With Prostate CancerRecruitingNCT05989854Not applicable
- Comparing the Efficacy and Safety of Rezvilutamide+ADT+Docetaxel Versus Rezvilutamide +ADT in the mHSPCRecruitingNCT05983783Phase 3
- Outpatient Laparoscopic Radical ProstatectomyRecruitingNCT05975775
- Intermittent Androgen Deprivation Therapy in the Era of AR Pathway InhibitorsRecruitingNCT05974774Phase 3
- Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer PatientsAvailableNCT05974410
- Trial of QLH12016 in Patients With Metastatic Castration Resistant Prostate CancerNot yet recruitingNCT05973149Phase 1
- Interstitial Assessment of Architectural Heterogeneity in Prostate Cancer Using a Fine Needle Photoacoustic ProbeRecruitingNCT05965180
- Lidocaine Combined With Sufentanil for Preventing Catheter-related Bladder DiscomfortNot yet recruitingNCT05957653Phase 4
- Head-to-head Comparison of [68Ga]Ga-PSMA-D5 With [68Ga]Ga-PSMA-11 PET/CT in PCa Diagnosis, Recurrence, and MetastasisRecruitingNCT05955677Early Phase 1
- Evaluation of Prostate Specific Membrane Antigen Positron Emission Tomography-Computed Tomography in Active Surveillance for Prostate CancErRecruitingNCT05948657Not applicable
- Circulating Tumor Cells and mpMRI for Non-invasive Diagnosis of Prostate Cancer(CMNDPC)RecruitingNCT05947188Not applicable
- This Study is Evaluating a New Radiation Treatment Technique for Patients Who Have Had Prostate Cancer, Undergone Surgery for Cancer, and Then Have Evidence That Their Prostate Cancer Has Returned.RecruitingNCT05946824Phase 2
- Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate CancerRecruitingNCT05946213Phase 3
- Testing an e-Health Intervention for Prostate Cancer Survivors' Mental and Sexual HealthRecruitingNCT05946161Not applicable
- The Effect of Frailty on Blood Biology Indicators, Quality of Life and Survival of Patients With Radical ProstatectomyNot yet recruitingNCT05941104
- Conducting Active Surveillance Without Prostate Biopsy for Patients With Low-risk Suspected Prostate CancerRecruitingNCT05940415
- 24 Gy in One Fraction Urethral-sparing "HDR Like" SBRT for Prostate CancerRecruitingNCT05936736Not applicable
- A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid TumorsRecruitingNCT05932862Phase 1
- High-Risk prostatE Cancer radiatiOn Versus surgERyRecruitingNCT05931419
- The Prostate Cancer, Genetic Risk, and Equitable Screening Study (ProGRESS)RecruitingNCT05926102Not applicable
- NLP-Based Feedback to Improve Risk Comms and Informed Shared Decision MakingRecruitingNCT05923684Not applicable
- FOG-001 in Locally Advanced or Metastatic Solid TumorsRecruitingNCT05919264Phase 1/2
- Exercise for Tumor Suppressive Impact in Men With Prostate Cancer at High-Risk of Progression on Active Surveillance: The REMOVE TrialRecruitingNCT05918263Not applicable
- Adenosine Signaling Modulation and Immune Checkpoint Inhibition With Hormone Sensitive Oligometastatic Prostate CancerRecruitingNCT05915442Phase 2
- A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid TumorsRecruitingNCT05914116Phase 1/2
- Actium-225-Prostate Specific Membrane Antigen Imaging & TherapyRecruitingNCT05902247Phase 1
- A Phase 2 Trial of Darolutamide as a Prostate-Specific Membrane Antigen (PSMA) Expression Enhancer in Patients With Localized Prostate CancerRecruitingNCT05900973Phase 2
- A Phase 1/2 Study of Personalized PSMA Radiopharmaceutical TherapyNot yet recruitingNCT05896371Phase 1/2